VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 210 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,268,512 | -60.5% | 455,551 | +3.4% | 0.00% | -66.7% |
| Q2 2023 | $10,810,788 | -6.2% | 440,717 | -11.0% | 0.00% | 0.0% |
| Q1 2023 | $11,525,818 | -8.2% | 495,308 | -0.2% | 0.00% | -25.0% |
| Q4 2022 | $12,559,479 | +28.7% | 496,226 | -1.9% | 0.00% | +33.3% |
| Q3 2022 | $9,755,000 | -21.1% | 505,946 | +4.2% | 0.00% | -25.0% |
| Q2 2022 | $12,370,000 | +1096.3% | 485,660 | +1108.5% | 0.00% | – |
| Q1 2022 | $1,034,000 | -86.5% | 40,188 | -78.1% | 0.00% | -100.0% |
| Q4 2021 | $7,671,000 | +403.3% | 183,201 | +423.3% | 0.00% | – |
| Q3 2021 | $1,524,000 | +3.0% | 35,008 | +11.9% | 0.00% | – |
| Q2 2021 | $1,479,000 | +65.8% | 31,290 | +79.8% | 0.00% | – |
| Q1 2021 | $892,000 | +191.5% | 17,398 | +52.1% | 0.00% | – |
| Q4 2020 | $306,000 | -68.6% | 11,438 | -51.9% | 0.00% | – |
| Q2 2020 | $975,000 | – | 23,804 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |